October 21, 2021
A health ministry drug pricing panel on October 20 launched full-fledged discussions on specific topics towards the reimbursement policy reform in April 2022, including so-called “spillover rules” in market expansion re-pricing and criteria for the price maintenance premium (PMP) ...read more